Anthony S. Fiorino, Chief Medical Officer and COO at IMMUNE PHARMACEUTICALS INC (IMNP), bought 50,000 shares at $0.26 ($13K) on 2018-05-17, disclosed to the SEC on 2018-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| BCLI | BUY | 2014-09-19 | $3K | — | Filing → |
| BCLI | BUY | 2014-09-16 | $5K | — | Filing → |